发明名称 HUMAN MONOCLONAL ANTIBODY TO INTERLEUKIN-5 AND METHOD AND COMPOSITION COMPRISING THE SAME
摘要 <P>PROBLEM TO BE SOLVED: To provide a high affinity antibody used in treating Il-5-mediated pathology in human, particularly to human anti-IL-5 antibodies. <P>SOLUTION: Provided are the antibodies and antigen-binding portions thereof that specifically bind to interleukin 5 (IL-5), which is preferably human IL-5. Provided are the human anti-IL-5 antibodies, including chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. Provided are the heavy and light chain immunoglobulin molecules derived from anti-IL-5 antibodies and nucleic acid molecules encoding such molecules. Provided are the methods of making anti-IL-5 antibodies, pharmaceutical compositions comprising these antibodies and methods of using the antibodies and compositions thereof for diagnosis and treatment. <P>COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2010011874(A) 申请公布日期 2010.01.21
申请号 JP20090243925 申请日期 2009.10.22
申请人 SCHERING CORP;ABGENIX INC 发明人 GREENFEDER SCOTT;CORVALAN JOSE
分类号 C12N15/09;A61K39/395;A61K45/00;A61P1/04;A61P7/00;A61P9/00;A61P11/00;A61P11/02;A61P11/06;A61P17/00;A61P17/04;A61P27/02;A61P27/14;A61P27/16;A61P33/10;A61P35/00;A61P37/06;A61P37/08;A61P43/00;C07K16/24;C07K16/46;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/02;C12N15/12;C12P21/08 主分类号 C12N15/09
代理机构 代理人
主权项
地址